N/A N=97 Effects on Cellulite Appearance
Body Fat Disorder
Primary: Percentage of Photographs Correctly Identified by Blinded Reviewers From the Independent Physician Reviewer Panel — 55.7 % of images identified correctly
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=68 Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.
Cellulite
Primary: Number of Subjects That Met the Individual Success Criteria — 19; 3 participants — p=<0.0001
Phase 4 N=14 A Study to Assess the Adverse Events and Effectiveness of Rapid Acoustic Pulse (RAP) Device for the Appearance of Cellulite in Adult Participants
Cellulite
Primary: Percentage of Before and After Side-by-side Photographs Correctly Identified by At Least 2 of 3 Blinded Reviewers From the Independent Physician Reviewer (IPR) Panel…
Phase 4 N=59 A Study to Assess the Adverse Events and Effectiveness of Rapid Acoustic Pulse (RAP) Device in Adult Participants for the Appearance of Cellulite
Cellulite
Primary: Percentage of Before and After Side-by-side Photographs Correctly Identified by At Least 2 of 3 Blinded Reviewers From the Independent Physician Reviewer (IPR) Panel…
N/A N=31 Profound Dermal and SubQ Cartridges for the Treatment of Cellulite
Cellulite
Primary: Improvement in Global Aesthetic Appearance of Cellulite in Treated Areas, as Assessed by Study Investigator Evaluations — 11; 7; 4; 16 Investigator Assessments
Phase 3 N=153 Real World CCH Study in Adult Females With Cellulite
Edematous Fibrosclerotic Panniculopathy (EFP) · Cellulite
Primary: The Proportion of Participants With Improved (+1 or Better) Score on I-GAIS for Either Posterolateral Thigh — 58 Participants
Phase 2 N=259 EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Edematous Fibrosclerotic Panniculopathy · Cellulite
Primary: Number of Participants That Were 2-level Composite (CR-PCSS and PR-PCSS) Responders During the Observation Phase — 19; 0; 16; 0 Participants
N/A N=22 Cryolipolysis and Subcision for Treatment of Cellulite
Cellulite
Primary: Blinded Rating of the Treatment Area (Cryolipolysis vs. Subcision) With the Best Cosmetic Appearance. — 22.22; 33.33; 44.44 Percentage of participants
Phase 3 N=422 Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women
Edematous Fibrosclerotic Panniculopathy (Cellulite)
Primary: 2-level Composite Responders for the Target Buttock — 12; 1; 202; 205 Participants — p=0.002
Phase 2 N=35 CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques
Edematous Fibrosclerotic Panniculopathy · Cellulite · Laxity; Skin
Primary: Percentage of 1-Level Responders (+1 or Better Score) on the Investigator-Global Aesthetic Improvement Scale (I-GAIS) for Either Buttock or Either Thigh — 85.7; 87.5…
Phase 2 N=375 EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Edematous Fibrosclerotic Panniculopathy · Cellulite
Primary: Percentage of Composite Responders of at Least 2-Level Improvement of Severity — 20; 3 Participants
Phase 2 N=150 A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Edematous Fibrosclerotic Panniculopathy (EFP)
Primary: Investigator Global Assessment of Aesthetic Improvement — 0.7; 0.9; 1.1; 0.5 units on a scale
Phase 2 N=64 Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
Edematous Skin
Primary: Aesthetic Appearance Improvement Likert Scores by Treatment Region at Day 22 — 1.08; 1.10; 0.75; 0.50 score on a scale
N/A N=74 CONtrolled Focal Fibrous Band Release Method Study
Cellulite
Primary: The Mean Change From Baseline to 3 Months in Cellulite Severity Scale (CSS) Score for Participants — 1.5 score on a scale — p=.0001
N/A N=55 Study of the Cabochon System for Improvement in the Appearance of Cellulite
Gynoid Lipodystrophy
Primary: Mean Change (Decrease) in Cellulite Severity — 2.0; 1.8 units on a scale
Phase 3 N=423 Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women
Edematous Fibrosclerotic Panniculopathy (Cellulite)
Primary: 2-level Composite Responders for the Target Buttock — 16; 4; 194; 209 Participants — p=0.006
N/A N=15 Clinical Evaluation of CelluTite Treatment
Cellulite of Thighs
Primary: Change in Cellulite Score Rated According to Cellulite Severity Scale (Dimples) — 2.45 score on a scale
Phase 3 N=483 Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)
Edematous Fibrosclerotic Panniculopathy · Cellulite
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) — 58; 29; 43; 45 Participants
Phase 4 N=48 Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite
Edematous Fibrosclerotic Panniculopathy (EFP) · Cellulite
Primary: Number of Participants by Buttock at Each Level of Bruising on the Investigator Assessment of Bruising Severity Scale at Day 4 — 0; 0; 0; 0 Participants
Phase 4 N=5 To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite.
Cellulite
Primary: Proportion of Subjects With ≥1-point Improvement on Investigator Global Aesthetic Improvement Scale (I-GAIS) at Day 90 (Buttocks) — 3; 2 Participants
N/A N=29 Safety and Effectiveness of Poly-l-lactic Acid (PLLA) for the Improvement in Appearance of Cellulite
Cellulite
Primary: Number of Aesthetic Improved Thighs of Responders According to Global Aesthetic Improvement Scale (GAIS) as Assessed Live by Treating Investigator at Month 9 — 23; 4; 1…
N/A N=45 Non-Invasive Reduction of Fat in the Inner Thighs
Body Fat Disorder
Primary: Percentage of Pre-Treatment Images Correctly Identified by Reviewers — 90.5 percentage of correct identifications
Phase 2 N=158 Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
Edematous Fibrosclerotic Panniculopathy · Cellulite
Primary: Investigator Clinician-Reported Photonumeric Cellulite Severity Scale (CR-PCSS) 2-level Responders — 6; 131; 8; 125 Participants
N/A N=22 Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Localized Lipodystrophy
Primary: Number of Participants With Mild to Moderate Reduction in Cellulite. — 3; 2 participants
N/A N=63 Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women
Obesity · Metabolic Syndrome
Primary: In Vivo Adipose Cell Formation (Adipogenesis) — -0.3; 1.8; -1.2; 2.1 percent
N/A N=20 (Macrolane VR30) in Buttocks Reshaping and contouringCellulite (Macrolane VR30) in Buttocks Reshaping and Contouring
Cellulite of the Buttocks
Primary: Number of Patients With Aesthetic Improvement of the Buttocks Using Investigator GAIS — 7 Participants
N/A N=60 Subcutaneous Fat Reduction in the Submental Area
Body Fat Disorder
Primary: Safety of CoolScupting in the Submental Area — 4 incidence of device- and/or procedure AE
Phase 2 N=91 Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks
Edematous Fibrosclerotic Panniculopathy · Cellulite
Primary: Percentage of Participants With at Least 1-Level Lower Score 3 to 5 Days After Initial CCH-aaes Injection, as Assessed by the Investigator Assessment of Bruising…
N/A N=19 Fat Layer Reduction in the Lateral Thighs Using CoolSculpting
Body Fat Disorder
Primary: Safety of the Zeltiq CoolSculpting System in the Outer Thighs — 8; 0 events
N/A N=60 Non-Invasive Reduction of Abdominal Fat
Fat Reduction
Primary: Proportion of Pre-treatment Images Correctly Identified — 128 photos — p=<0.001